Clinical Trial Update: Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC

View source ↗

Summary

This is a clinical trial update about adjuvant chemotherapy for high-risk pathologic stage I non-small cell lung cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Non-small Cell Lung Cancer Stage I | Status: COMPLETED